ReviewWorld journal of hepatology2026
Harnessing artificial intelligence in gastroenterology and hepatology: Current applications and future perspectives.
Review in World journal of hepatology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Artificial intelligence (AI) has made remarkable strides, becoming an essential tool in modern medicine. As AI continues to evolve, it is crucial to redefine its scope, classifications, and subtypes to better align with its clinical applications and potential. With a growing number of sophisticated models, AI is now widely used in gastroenterology and hepatology, offering new ways to enhance patient care. In gastroenterology, AI helps doctors identify lesions during endoscopy, detect gastrointestinal bleeding, and support the diagnosis and treatment of conditions like inflammatory bowel disease and gastrointestinal cancers. In hepatology, it aids in staging liver fibrosis, tracking disease progression, and predicting hepatocellular carcinoma risks. Machine learning further personalizes treatment plans, helping physicians make more informed decisions. However, despite its promise, AI still faces hurdles, including biases in data, ethical considerations, regulatory challenges, and the need for better transparency. Moving forward, refining these models, conducting extensive validation studies, and integrating AI seamlessly into clinical practice will be crucial in fully realizing its benefits for gastroenterology and hepatology.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.